Harbour Investments’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
Other funds holding JAZZ
Harbour Investments's JAZZ Position: Q2 2026 in Review
Harbour Investments reduced its Jazz Pharmaceuticals (JAZZ) stake by 1.4% in Q2 2026, selling an estimated $4.16K and leaving 1,365 shares worth $329K. The position accounts for ﹤0.01% of the portfolio, ranked #1325.
Harbour Investments first reported a position in JAZZ in Q1 2021 and has held it in 21 quarters since. 646 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.
- Harbour Investments held 1,365 shares of Jazz Pharmaceuticals worth $329K as of Q2 2026.
- Harbour Investments sold 19 Jazz Pharmaceuticals shares in Q2 2026, an estimated $4.16K.
- Jazz Pharmaceuticals made up ﹤0.01% of Harbour Investments's portfolio in Q2 2026, its #1325 holding.
- Harbour Investments first reported a position in Jazz Pharmaceuticals in Q1 2021 and has held it in 21 quarters since.
- 646 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.
Based on Harbour Investments's 13F filing for Q2 2026, filed 12 Aug 2026.